{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:20:56Z","timestamp":1783164056133,"version":"3.54.6"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jns.2024.122950","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T12:07:07Z","timestamp":1709726827000},"page":"122950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Efficacy and safety of ketamine for pediatric and adolescent super-refractory status epilepticus and the effect of cerebral inflammatory conditions"],"prefix":"10.1016","volume":"459","author":[{"given":"Ichiro","family":"Kuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Fukuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Nukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoko","family":"Amo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Rinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atushi","family":"Ujiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Togawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Shiomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2024.122950_bb0005","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia."},{"key":"10.1016\/j.jns.2024.122950_bb0010","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/brain\/awu042","article-title":"Seizure burden is independently associated with short term outcome in critically ill children","volume":"137","author":"Payne","year":"2014","journal-title":"Brain."},{"key":"10.1016\/j.jns.2024.122950_bb0015","doi-asserted-by":"crossref","first-page":"e2749","DOI":"10.1212\/WNL.0000000000012032","article-title":"Electrographic seizures and outcome in critically ill children","volume":"96","author":"Fung","year":"2021","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2024.122950_bb0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/CCM.0b013e3182668035","article-title":"Electrographic status epilepticus is associated with mortality and worse short-term outcome in critically ill children","volume":"41","author":"Topjian","year":"2013","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.jns.2024.122950_bb0025","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0149-2918(98)80106-9","article-title":"Use of midazolam in the treatment of refractory status epilepticus","volume":"20","author":"Hanley","year":"1998","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jns.2024.122950_bb0030","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1093\/brain\/awr215","article-title":"The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol","volume":"134","author":"Shorvon","year":"2011","journal-title":"Brain."},{"key":"10.1016\/j.jns.2024.122950_bb0035","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/PCC.0000000000000173","article-title":"Intensive care treatment of uncontrolled status epilepticus in children: systematic literature search of midazolam and anesthetic therapies*","volume":"15","author":"Wilkes","year":"2014","journal-title":"Pediatr. Crit. Care Med."},{"key":"10.1016\/j.jns.2024.122950_bb0040","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/0883073817698629","article-title":"Increasing ketamine use for refractory status epilepticus in US pediatric hospitals","volume":"32","author":"Keros","year":"2017","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.jns.2024.122950_bb0045","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1212\/WNL.51.6.1765","article-title":"Refractory status epilepticus: response to ketamine","volume":"51","author":"Sheth","year":"1998","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2024.122950_bb0050","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1212\/WNL.0b013e318278b685","article-title":"Efficacy and safety of ketamine in refractory status epilepticus in children","volume":"79","author":"Rosati","year":"2012","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2024.122950_bb0055","doi-asserted-by":"crossref","first-page":"e1227","DOI":"10.1212\/WNL.0000000000200889","article-title":"Ketamine for management of neonatal and pediatric refractory status epilepticus","volume":"99","author":"Jacobwitz","year":"2022","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2024.122950_bb0060","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/epi.12247","article-title":"Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study","volume":"54","author":"Gaspard","year":"2013","journal-title":"Epilepsia."},{"key":"10.1016\/j.jns.2024.122950_bb0065","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.yebeh.2018.06.029","article-title":"The etiology and prognosis of super-refractory convulsive status epilepticus in children","volume":"86","author":"Lu","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jns.2024.122950_bb0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.seizure.2017.09.003","article-title":"Factors associated with occurrence and outcome of super-refractory status epilepticus","volume":"52","author":"Mad\u017ear","year":"2017","journal-title":"Seizure."},{"issue":"2023","key":"10.1016\/j.jns.2024.122950_bb0075","doi-asserted-by":"crossref","first-page":"1251914","DOI":"10.3389\/fped.2023.1251914","article-title":"Neuroinflammation and status epilepticus: a narrative review unraveling a complex interplay","volume":"11","author":"Foiadelli","year":"2023","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.jns.2024.122950_bb0080","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.yfrne.2011.12.002","article-title":"Cytokines and brain excitability","volume":"33","author":"Galic","year":"2012","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.jns.2024.122950_bb0085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuropharm.2014.10.027","article-title":"Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability","volume":"96","author":"Vezzani","year":"2015","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.jns.2024.122950_bb0090","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/jnnp-2014-309388","article-title":"M. Hayashi, intrathecal overproduction of proinflammatory cytokines and chemokines in febrile infection-related refractory status epilepticus","volume":"86","author":"Sakuma","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2024.122950_bb0095","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s40263-018-0569-6","article-title":"Ketamine for refractory status epilepticus: a systematic review","volume":"32","author":"Rosati","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jns.2024.122950_bb0100","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1474-4422(15)00042-3","article-title":"Status epilepticus in adults","volume":"14","author":"Betjemann","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2024.122950_bb0105","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA(a) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2024.122950_bb0110","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1523\/JNEUROSCI.0900-05.2005","article-title":"Status epilepticus increases the intracellular accumulation of GABAA receptors","volume":"25","author":"Goodkin","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2024.122950_bb0115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.nbd.2012.12.015","article-title":"Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus","volume":"54","author":"Naylor","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jns.2024.122950_bb0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1474-4422(10)70214-3","article-title":"Acute encephalopathy with inflammation-mediated status epilepticus","volume":"10","author":"Nabbout","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2024.122950_bb0125","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1523\/JNEUROSCI.1901-08.2008","article-title":"Postnatal inflammation increases seizure susceptibility in adult rats","volume":"28","author":"Galic","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2024.122950_bb0130","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.nbd.2009.07.025","article-title":"Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats","volume":"36","author":"Galic","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jns.2024.122950_bb0135","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.bbi.2008.03.009","article-title":"The role of cytokines in the pathophysiology of epilepsy","volume":"22","author":"Vezzani","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jns.2024.122950_bb0140","doi-asserted-by":"crossref","first-page":"15879","DOI":"10.1523\/JNEUROSCI.0530-13.2013","article-title":"TNF-\u03b1 downregulates inhibitory neurotransmission through protein phosphatase 1-dependent trafficking of GABA(a) receptors","volume":"33","author":"Pribiag","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2024.122950_bb0145","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1523\/JNEUROSCI.4486-04.2005","article-title":"Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha","volume":"25","author":"Stellwagen","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2024.122950_bb0150","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41582-019-0217-x","article-title":"Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy","volume":"15","author":"Vezzani","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jns.2024.122950_bb0155","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ana.20358","article-title":"Interleukin-1beta contributes to the generation of experimental febrile seizures","volume":"57","author":"Dub\u00e9","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2024.122950_bb0160","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1111\/j.1528-1167.2005.00286.x","article-title":"Febrile convulsions induced by the combination of lipopolysaccharide and low-dose kainic acid enhance seizure susceptibility, not epileptogenesis, in rats","volume":"46","author":"Heida","year":"2005","journal-title":"Epilepsia."},{"key":"10.1016\/j.jns.2024.122950_bb0165","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.bbi.2011.03.018","article-title":"IL-1 receptor\/toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures","volume":"25","author":"Vezzani","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jns.2024.122950_bb0170","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3389\/fneur.2019.00684","article-title":"Neuronal NMDAR currents of the hippocampus and learning performance in autoimmune anti-NMDAR encephalitis and involvement of TNF-\u03b1 and IL-6","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2024.122950_bb0175","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1523\/JNEUROSCI.3338-07.2008","article-title":"Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord","volume":"28","author":"Kawasaki","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2024.122950_bb0180","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/s41598-018-19988-6","article-title":"Cerebrospinal fluid chemokine patterns in children with enterovirus 71-related encephalitis","volume":"26","author":"Liu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jns.2024.122950_bb0185","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cyto.2010.03.001","article-title":"IL-17 is elevated in cerebrospinal fluids in bacterial meningitis in children","volume":"51","author":"Asano","year":"2010","journal-title":"Cytokine."},{"key":"10.1016\/j.jns.2024.122950_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23198","article-title":"Cytokine characteristic of cerebrospinal fluid from children with enteroviral meningitis compared to bacterial meningitis","volume":"34","author":"Xu","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.jns.2024.122950_bb0195","article-title":"Cytokines and chemokines profile in encephalitis patients: a meta-analysis","volume":"17","author":"Khaboushan","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2024.122950_bb0200","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1111\/epi.16275","article-title":"Etiology is the key determinant of neuroinflammation in epilepsy: elevation of cerebrospinal fluid cytokines and chemokines in febrile infection-related epilepsy syndrome and febrile status epilepticus","volume":"60","author":"Kothur","year":"2019","journal-title":"Epilepsia."},{"key":"10.1016\/j.jns.2024.122950_bb0205","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/acn3.51832","article-title":"CSF neopterin and quinolinic acid are biomarkers of neuroinflammation and neurotoxicity in FIRES and other infection-triggered encephalopathy syndromes","volume":"10","author":"Dale","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jns.2024.122950_bb0210","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2044.2008.05835.x","article-title":"Anaesthesia in haemodynamically compromised emergency patients: does ketamine represent the best choice of induction agent?","volume":"64","author":"Morris","year":"2009","journal-title":"Anaesthesia."},{"key":"10.1016\/j.jns.2024.122950_bb0215","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00000542-197212000-00008","article-title":"Circulatory responses to ketamine anesthesia","volume":"37","author":"Tweed","year":"1972","journal-title":"Anesthesiology."},{"key":"10.1016\/j.jns.2024.122950_bb0220","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.eplepsyres.2013.01.007","article-title":"Ketamine use in the treatment of refractory status epilepticus","volume":"105","author":"Synowiec","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jns.2024.122950_bb0225","doi-asserted-by":"crossref","first-page":"e2286","DOI":"10.1212\/WNL.0000000000010611","article-title":"Ketamine to treat super-refractory status epilepticus","volume":"95","author":"Alkhachroum","year":"2020","journal-title":"Neurology."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24000856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24000856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:05:13Z","timestamp":1758384313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X24000856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":45,"alternative-id":["S0022510X24000856"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2024.122950","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of ketamine for pediatric and adolescent super-refractory status epilepticus and the effect of cerebral inflammatory conditions","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2024.122950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122950"}}